IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024
IQVIA Holdings (NYSE:IQV) has announced that Ron Bruehlman, executive vice president and chief financial officer, will present at the UBS Healthcare Conference in Rancho Palos Verdes, California. The presentation is scheduled for November 13, 2024, at 1:15 p.m. ET. Interested parties can access a live audio webcast of the presentation through the IQVIA Investor Relations website, with a replay available later the same day.
IQVIA Holdings (NYSE:IQV) ha annunciato che Ron Bruehlman, vicepresidente esecutivo e direttore finanziario, presenterà alla Conferenza Sanitaria UBS a Rancho Palos Verdes, California. La presentazione è programmata per il 13 novembre 2024, alle 13:15 ET. Le parti interessate possono accedere a una trasmissione audio in diretta della presentazione attraverso il sito web delle Relazioni con gli Investitori di IQVIA, con una registrazione disponibile più tardi lo stesso giorno.
IQVIA Holdings (NYSE:IQV) ha anunciado que Ron Bruehlman, vicepresidente ejecutivo y director financiero, presentará en la Conferencia de Salud UBS en Rancho Palos Verdes, California. La presentación está programada para el 13 de noviembre de 2024, a la 1:15 p.m. ET. Las partes interesadas pueden acceder a una transmisión web en vivo de la presentación a través del sitio web de Relaciones con Inversores de IQVIA, con una repetición disponible más tarde el mismo día.
IQVIA Holdings (NYSE:IQV)가 Ron Bruehlman 최고 재무 책임자이자 부사장이 캘리포니아 랜초팔로스베르데스에서 열리는 UBS 헬스케어 컨퍼런스에서 발표할 것이라고 발표했습니다. 발표는 2024년 11월 13일, 오후 1시 15분 ET로 예정되어 있습니다. 관심 있는 분들은 IQVIA 투자자 관계 웹사이트를 통해 발표의 실시간 오디오 웹캐스트에 접속할 수 있으며, 같은 날 이후에 다시 볼 수 있습니다.
IQVIA Holdings (NYSE:IQV) a annoncé que Ron Bruehlman, vice-président exécutif et directeur financier, présentera à la Conférence de Santé UBS à Rancho Palos Verdes, Californie. La présentation est prévue pour le 13 novembre 2024 à 13h15 ET. Les parties intéressées peuvent accéder à un webinaire audio en direct de la présentation via le site Web des Relations avec les Investisseurs d'IQVIA, avec une rediffusion disponible plus tard dans la journée.
IQVIA Holdings (NYSE:IQV) hat bekannt gegeben, dass Ron Bruehlman, Executive Vice President und Chief Financial Officer, auf der UBS Healthcare Conference in Rancho Palos Verdes, Kalifornien, präsentieren wird. Die Präsentation ist für 13. November 2024 um 13:15 Uhr ET geplant. Interessierte Parteien können über die Investor Relations-Website von IQVIA auf einen Live-Audio-Webcast der Präsentation zugreifen, mit einer Wiederholung, die später am selben Tag verfügbar ist.
- None.
- None.
A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
IQVIAFIN
View source version on businesswire.com: https://www.businesswire.com/news/home/20241106622334/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)
+1.919.780.3221
Source: IQVIA Holdings Inc.
FAQ
When will IQVIA CFO Ron Bruehlman speak at the UBS Healthcare Conference 2024?
Where can I watch IQVIA's presentation at the UBS Healthcare Conference 2024?
Where will the UBS Healthcare Conference 2024 featuring IQV be held?
Will there be a replay available of IQVIA's UBS Healthcare Conference presentation?
